Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Endo

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Endo's 2013 CNS (central nervous system) sales performance.

Endo Health Solutions

Sourcing R&D innovation: why pharma companies need to evolve their business models

Sourcing R&D innovation: why pharma companies need to evolve their business models

Amgen developed a portfolio of supportive cancer care drugs including Epogen, Neupogen and Aranesp, and Endo Pharmaceuticals developed a pipeline of pain products that includes Lidoderm, Percocet and Opana.

Will biosimilars ever catch on in the US?

Will biosimilars ever catch on in the US? The latest example involved Endo Pharmaceuticals paying Impax Laboratories $112m to delay selling a generic version of Opana ER.

UK to add addiction warnings to opioids as use soars

UK to add addiction warnings to opioids as use soars Endo, Teva and Abbott are among other companies also accused of exaggerating the benefits of their products and playing down safety concerns.

Sobi names Holly May VP of sales and marketing, US

Sobi names Holly May VP of sales and marketing, US Prior to her 17-year career at Sanofi, May held various sales positions at DuPont Pharmaceuticals and Endo.

Endo faces industry-first FDA call to pull its opioid painkiller

Endo faces industry-first FDA call to pull its opioid painkiller Endo’s shares dropped to 13.6% following the request and the Irish drug maker said that it’s “evaluating the full range of potential options”. ... Last year, Opana generated sales of $159m for Endo, down from its peak of around $300m and the drug

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
BOLDSCIENCE

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....